Company profile · Onderzoeks- & kennisinstelling
Nimvec Therapeutics
- Biotechnology
- Onderzoeks- & kennisinstelling
- Leiden
- Biotechnology · Leiden
- Employees
- 2–10
- Founded
- 2025
- Province
- Zuid-Holland
- Country
- Netherlands
About Nimvec Therapeutics
NIMVEC™ is redefining gene therapy with a next-generation, non-immunogenic viral vector platform and the only one that can be safely re-dosed. Pioneering safe, non-immunogenic solutions for lasting therapeutic impact, NIMVEC™ enables scalable manufacturing and powers a pipeline of curative gene therapies for monogenic, autoimmune, and inflammatory diseases.
Address
Headquarters
LeidenZuid-Holland, Netherlands
Team by function
Based on 5 public job profiles as of 3 September 2026.
- Operations2
- Executive / C-Suite1
- Finance / Accounting1
- HR / People / Recruiting1
Similar companies
Companies with a similar profile, Zuid-Holland first.
Immunetune
Biotechnology · Leiden
2–10 employeesView profile
NTrans Technologies BV
Biotechnology · Leiden
2–10 employeesView profile
Vico Therapeutics
Biotechnology · Leiden
11–50 employeesView profile
20Med Therapeutics
Biotechnology · Leiden
11–50 employeesView profile
MIMETAS
Biotechnology · Oegstgeest
51–200 employeesView profile
NecstGen
Pharmaceuticals · Leiden
11–50 employeesView profile